Michael Abrams - 31 Aug 2023 Form 4 Insider Report for Arch Therapeutics, Inc. (ARTHQ)

Role: CHIEF FINANCIAL OFFICER
Signature: /s/ Michael Abrams
Issuer symbol: ARTHQ
Transactions as of: 31 Aug 2023
Net transactions value: +$2,830
Form type: 4
Filing time: 08 Sep 2023, 18:47:59 UTC
Previous filing: 10 Nov 2022
Next filing: 22 Nov 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ARTH	Common Stock	Purchase	$2,830	+10,292		$0.2750	10,292	31 Aug 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ARTH	Warrants (right to buy)	Award		+20,584			20,584	31 Aug 2023	Common Stock	20,584	$1.00	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The warrants are exercisable after the earlier of (A) the six-month anniversary after the date of issuance and (B) the date that a registration statement registering the shares underlying the warrants is declared effective.
F2	The warrants were sold as part of a unit with the shares of common stock reported in Table I, at a price of $0.275 per share of common stock and accompanying warrant to purchase two shares of common stock.